Outbreak of IMI-1 Carbapenemase-producing colistin-resistant Enterobacter cloacae on the French island of Mayotte (Indian Ocean)

The emergence of carbapenemase-producing Enterobacteriaceae (CPE) is currently a worldwide public health issue [1]. Significant population flows from southern Africa and the Indian sub-continent to the Indian Ocean islands can contribute to the dissemination of these multidrug resistant bacteria (MDR) in the Mayotte and Reunion islands, two French overseas departments located in the Southwest Indian Ocean, close to Madagascar, with a population of 250,000 and 850,000 inhabitants, respectively. The MDR screening program carried out at the Mayotte Medical Center (MMC) and F élix Guyon University Hospital (FGUH) of Reunion Island isolated Enterobacter cloacae producing the uncommon class A carbapenemase, IMI-1, from several patients from Mayotte.

Source: International Journal of Antimicrobial Agents - May 25, 2018 Category: Drugs & Pharmacology Authors: Guillaume Miltgen, R émy A. Bonnin, Catherine Avril, Thierry Benoit-Cattin, Daniel Martak, Alexandre Leclaire, Nicolas Traversier, Bénédicte Roquebert, Marie-Christine Jaffar-Bandjee, Nathalie Lugagne, Laurent Filleul, Marion Subiros, Anne-Marie de Mon Tags: Short Communication Source Type: research